MetaCap

Alpha Pro Tech (APT) vs Envoy Medical (COCH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Envoy Medical (COCH) has outperformed Alpha Pro Tech (APT) over the past year, gaining 829.3% versus a gain of 29.3%. Over five years, APT leads with a -7.0% price change compared with -31.6% for COCH. Alpha Pro Tech is the larger company by market cap ($61.2 million vs $51.9 million), about 1.2 times the size, while Envoy Medical is growing revenue faster (+7.1% vs +2.3%).

Alpha Pro Tech converts more of its revenue into profit, with a net margin of 6.0% versus -9857.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

APT+29.28%COCH+829.26%
+939%+423%-93%
Nov 21, 20251 yearNov 20, 2026
APT+13.52%COCH-31.35%
+33%-34%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

APT versus COCH key metrics
MetricAPTCOCH
Share price$5.96$6.70
Market cap$61.17M$51.89M
1-day change-4.49%0.00%
YTD return+34.23%+913.62%
1-year return+29.28%+829.26%
5-year return-7.02%-31.56%
P/E ratio (TTM)12.16—
Forward P/E5.14—
EPS (TTM)$0.49$-4.57
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$59.14M$241.00K
Revenue growth (YoY)+2.25%+7.11%
Net income (latest FY)$3.53M$-23.76M
Gross margin38.11%-262.66%
Operating margin6.49%-9240.66%
Net margin5.97%-9857.26%
52-week high$7.50$9.54
52-week low$4.34$3.63
Distance from 52-week high-20.53%-29.77%
Analyst consensus—strong_buy
Avg. price target upside—-67.61%
Average volume55.05K16.73K
Shares outstanding10.26M7.74M
Employees12243
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • COCH has outperformed APT by 800.0 percentage points over the past year.
  • Alpha Pro Tech is more profitable, keeping 6.0 cents of every revenue dollar as net income versus -9857.3 cents for Envoy Medical.

About Alpha Pro Tech

APT stock →

Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel and infection control products in the United States and internationally. The company operates through two business segments, Building Supply and Disposable Protective Apparel.

Health Care · Industrial Specialties · 122 employees

About Envoy Medical

COCH stock →

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire.

Health Care · Industrial Specialties · 43 employees

APT vs COCH FAQ

Which is bigger, Alpha Pro Tech or Envoy Medical?

Alpha Pro Tech (APT) is larger, with a market capitalization of $61.17M compared with $51.89M for Envoy Medical (COCH).

Which stock has performed better over the past year, APT or COCH?

COCH returned +829.26% over the past 12 months, compared with +29.28% for APT (price return, excluding dividends). Past performance does not predict future results.

Are Alpha Pro Tech and Envoy Medical in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons